Story perspectives

AMA Launches Vaccine Review Amid Trust Crisis with CDC

2/11/2026

Summary

Story summary

The American Medical Association (AMA) announced a new review process for vaccine safety and efficacy in collaboration with the Vaccine Integrity Project at the University of Minnesota.
This initiative addresses decreased trust in the CDC following significant changes in federal vaccine recommendations.
The AMA criticized the CDC's Advisory Committee on Immunization Practices (ACIP), stating it has "effectively collapsed."
The review will focus on vaccines for influenza, COVID-19, and RSV, aiming for transparent, evidence-based guidance.
The Department of Health and Human Services (HHS) refuted the AMA's claims, asserting that ACIP remains the authoritative body for U.S. vaccine recommendations.

1 of 1

Story summary

The American Medical Association (AMA) announced a new review process for vaccine safety and efficacy in collaboration with the Vaccine Integrity Project at the University of Minnesota.
This initiative addresses decreased trust in the CDC following significant changes in federal vaccine recommendations.
The AMA criticized the CDC's Advisory Committee on Immunization Practices (ACIP), stating it has "effectively collapsed."
The review will focus on vaccines for influenza, COVID-19, and RSV, aiming for transparent, evidence-based guidance.
The Department of Health and Human Services (HHS) refuted the AMA's claims, asserting that ACIP remains the authoritative body for U.S. vaccine recommendations.